April 2015 | eNews The NIH continues to recognize DF/HCC as a leader in cancer research by awarding funding to a number of our research initiatives. Recently, this... | [more]
Welcome to Dana-Farber/Harvard Cancer CenterDana-Farber/Harvard Cancer Center (DF/HCC) is the largest comprehensive cancer center in the world, bringing together the cancer research efforts of our seven member institutions: Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, and Massachusetts General Hospital.
Funded by a grant from the National Cancer Institute, we have joined these seven renowned Harvard-affiliated medical centers into one collective force dedicated to the fight against cancer. Based in Boston, DF/HCC consists of more than 1,000 researchers with a singular goal -- to find new and innovative ways to combat cancer.
- DF/HCC Spore in Prostate Cancer Request for Applications: Career Enhancement and Developmental Project Awards Posted: 04-24-15
- Seminars in Oncology: "The Shifting Intricacies of Tumor-Microenvironment Interactions in the Bone Marrow" Posted: 04-22-15
- PAR: Cancer Prevention Control-LMIC Supplement to P30 CCSGs Posted: 04-10-15
Latest Cancer News
April 2015 | eNews Rebecca Heist, MD (MGH) and colleagues are conducting a Phase Ib study to evaluate the safety and efficacy of the PD-L1 inhibitor MDPL3280A combined... | [more]
April 2015 | eNewsEpidemiology—the study of disease conditions and risk factors within defined populations—as with other branches of medicine, is becoming ever more... | [more]